Breaking News

Cancer Diagnostics Market Disrupted By CAR-T Cell Therapy


Rising incidences of cancer worldwide, technological advancements in oncological diagnostic techniques, and increasing demand for effective screening tests are some of the major factors propelling demand in the cancer diagnostics market, according to a study by IndustryARC. The report estimated the global cancer diagnostics market to have been valued at $135 billion in 2018 and projects it to increase at a CAGR of 6.2% during the forecast period 2019 to 2025.

The report titled, ‘Cancer Diagnostics Market: By Product Type (Next-generation Sequencing, Microarrays, PCR, Flow Cytometry, In situ Hybridization, Others), Cancer Type (Breast, Ovarian, Thyroid, Kidney, Blood, Prostate, Others) & By Geography – Forecast (2019 – 2025)’, describes imperative aspects of the industry including market drivers, market value chain, restraints, growth indicators, market trends, challenges, future outlook, and market insights.

View Full Table Of Content Of Cancer Diagnostics Market  :

Cancer Diagnostics Market: Leading Segments
In the global cancer diagnostics market, North America registered the highest share of demand at 37% in 2018. Growing usage of latest technologies for treatment, rising awareness pertaining to cancer treatment, an increase in the reported incidences of cancer coupled with easy access to highly developed healthcare infrastructure contribute to North America’s dominance in the global cancer diagnostics market. According to the National Cancer Institute, breast cancer is not only the most diagnosed type of cancer among women, but it is also the most common cancer diagnosed for both genders. Key market players are thus capitalizing on this application segment, which is expected to grow at a CAGR of 28% through to 2025.

Cancer Diagnostics Market Disruptive Trends
Some of the latest disruptive trends are listed below:

·Cancer Diagnostics Augmented by Artificial Intelligence and Machine Learning:
Ongoing research pertaining to use of machine learning and natural language processing to create targeted cancer treatments, pair machine learning with computer vision, help identify tumor progression, and creating algorithms that help scientists understand how cancer develops and how to fight them is expected to boost demand for the cancer diagnostics market.

·Nanotechnology for Cancer Diagnostics:
Nanoscale devices are 100 to 10000 times smaller than human cells, which enable them to gain access to inconspicuous areas of the body in order to detect diseases and facilitate new ways of treatment.

·CAR-T cell therapy:
Chimeric Antigen Receptor Therapy (CAR-T) cell therapy, a type of immunotherapy, is one of the most promising advancements in the healthcare industry. It isolates and extracts a patient’s own T-cells, and reengineers those cells with new proteins that recognize and destroy cancer cells once they’re reinfused back into the patient’s body.

·Advanced Blood Test:
Liquid biopsies assess mutations and other changes in DNA from tumor cells in the blood and thus provide insight during the early stages of cancer. This non-invasive cancer test continues to show promise as a tool for routine cancer screenings and as a potential alternative to tumor biopsy.

Cancer Diagnostics Market: Competitive Landscape
Some of the key companies identified in the report that are currently holding majority share in the global cancer diagnostics market are: BioMark Diagnostics Inc., Biotheranostics, Inc., Cancer Diagnostics, Inc., Arquer Diagnostics Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, GE Healthcare, QIAGEN N.V., Thermo Fisher Scientific, Inc., and Illumina, Inc.

Talk to one of our sales representative about the full report by providing your details in the link below:

Related Reports:
A. Cancer Hormone Therapy Market

B. Cancer Testing/Screening Market

What can you expect from the report?
The Cancer Diagnostics Market is Prepared with the Main Agenda to Cover the following 20 points:
1. Cancer Diagnostics Market Size by Product Categories & Application
2. Cancer Diagnostics Market trends & Relevant Market Data
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End-user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Cancer Diagnostics Market Demand Analysis (Revenue & Volume)
12. Country-level Analysis
13. Competitor Analysis
14. Cancer Diagnostics Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Cancer Diagnostics Market Strategic Analysis
18. Cancer Diagnostics Market Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Cancer Diagnostics Market Revenue and Volume Analysis

Frequently Asked Questions:
Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:
1. Increase the level of data in the application or end-user industry.

2. Increase the number of countries in geography chapter.

3. Find out market shares for other smaller companies or companies which are of interest to you.

4. Company profiles can be requested based on your interest.

5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end-use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more our consulting services.


Media Contact:
Mr. Venkat Reddy
Sales Manager
Email 1:
Or Email 2:
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.


Go to website